A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics

ConclusionThe ATPCI study will shed further light on the management of contemporary angina patients after PCI. Results are expected in 2019.
Source: American Heart Journal - Category: Cardiology Source Type: research